Morning Overview on MSN
Women taking Ozempic-style drugs were about 30% less likely to develop breast cancer, a large study found
A retrospective study of more than 110,000 women ages 45 to 80 found that those taking GLP-1 receptor agonist medications ...
A study published in Current Molecular Pharmacology provides a comprehensive analysis of microRNA-29a (miR-29a) as a pivotal regulator in cancer development, and examines how natural bioactive ...
A distinct signaling pathway called TNF- drives the transformation of epithelial cells into aggressive tumor cells. During cancer progression, cells activate their own TNF- program and become invasive ...
Researchers at Mayo Clinic have uncovered a previously hidden step in how the immune system prepares to fight cancer, a ...
Hosted on MSN
New research suggests cancer may develop earlier than we thought — but simple changes can help prevent it
Cancer screening can feel like a rite of passage as we get older: skin cancer checks in your late 30s, a mammogram at age 40, a colonoscopy at age 45. However, as young cancer cases have skyrocketed, ...
Cancer is often considered a disease of aging. Older adults are at higher risk because they have had more time to accumulate ...
Chronic inflammation is a major cause of cancer worldwide. Interleukin 33 (IL-33) is a critical initiator of cancer-prone chronic inflammation; however, its induction mechanism by environmental causes ...
There is a promising shift toward nonsurgical treatment strategies in early breast cancer, as clinicians aim to reduce harm ...
Development of acquired therapeutic resistance limits the efficacy of cancer treatments and accounts for therapeutic failure in most patients. How resistance arises, varies across cancer types and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results